Efficacy of mHealth Apps for Health in a Low-income, Type II Diabetic, Hispanic Population
Launched by SAN DIEGO STATE UNIVERSITY · Mar 6, 2022
Trial Information
Current as of August 20, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how effective mobile health apps are in helping people improve their health, specifically for those with type II diabetes who come from low-income Hispanic backgrounds. The goal is to see if using these apps can lead to better health outcomes, like managing blood sugar levels and weight. Participants in the study will need to commit to a six-month program where they will weigh themselves daily and check their blood sugar levels before and after meals.
To be eligible for this trial, participants must be between 18 and 64 years old, diagnosed with type II diabetes, have a body mass index (BMI) of 27 or higher, and earn less than $47,520 a year. They also need to regularly check their blood sugar and have a smartphone to download the health apps. Participants who join can expect to closely monitor their health and receive support through the mobile apps. This study is currently recruiting, and it's a great opportunity for those who want to take an active role in managing their diabetes.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Diagnosed with type II diabetes
- • Between the age of 18-64
- • BMI ≥ 27
- • Individual annual income less than $47,520 \[Covered CA income guidelines and salary restrictions\]
- • Hispanic and/or Latinx origin
- • Monitors blood glucose regularly
- • Owns or has access to a bathroom weight scale
- • Owns a smartphone and willing to download mobile apps
- Exclusion Criteria:
- • Does not check blood glucose at least once per day
- • On medications that promote weight gain such as antipsychotic, antidepressant, and steroid hormone medications.
- • Medications for diabetes such as insulin, thiazolidinediones or sulfonylureas are okay
About San Diego State University
San Diego State University (SDSU) is a leading academic institution recognized for its commitment to research and innovation in various fields, including health sciences. With a robust infrastructure for clinical trials, SDSU engages in cutting-edge research aimed at advancing medical knowledge and improving patient care. The university fosters collaboration among interdisciplinary teams of researchers, clinicians, and students, enabling the development of novel therapeutic interventions and evidence-based practices. SDSU's dedication to ethical standards and rigorous scientific methodologies ensures that its clinical trials contribute valuable insights to the medical community and enhance public health outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
San Diego, California, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials